Aziyo Biologics (ELUT)
NASDAQ:ELUT
US Market
Holding ELUT?
Track your performance easily

Aziyo Biologics (ELUT) Cash flow

58 Followers

Aziyo Biologics Cash Flow

ELUT's free cash flow for Q2 2024 was $-4.40M. For the 2024 fiscal year, ELUT's free cash flow was decreased by $-172.00K and operating cash flow was $-4.40M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -21.21M$ -21.76M$ -21.43M$ -15.45M$ -13.63M$ -7.22M
Investing Cash Flow
$ 14.64M$ 14.21M$ -540.00K$ -369.00K$ -640.00K$ -577.00K
Financing Cash Flow
$ 15.43M$ 9.84M$ 8.54M$ 6.71M$ 51.21M$ 7.98M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 64.53M$ 19.28M$ 16.99M$ 30.43M$ 39.53M$ 2.59M
Income Tax Paid Supplemental Data
----$ 32.00K$ 25.00K
Interest Paid Supplemental Data
$ 4.71M$ 2.32M$ 5.48M$ 4.98M$ 5.11M$ 4.40M
Issuance Of Capital Stock
$ 22.48M$ 10.09M$ 10.09M$ 13.75M$ 43.02M$ 2.28M
Issuance Of Debt
$ -3.96M$ -1.96M$ 1.62M$ -4.53M$ 6.98M$ 4.25M
Repayment Of Debt
$ -2.00M-$ -18.61M$ -2.78M$ -300.00K$ 2.48M
Free Cash Flow
$ -21.30M$ -22.15M$ -21.97M$ -15.81M$ -14.27M$ -7.80M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Aziyo Biologics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis